P1 - “FIP Talks”: Changing science, practice and education outcomes for the better

Armadillo

Organised by the FIP Programme Committee

Chairs

Lars-Åke Söderlund (FIP Programme Committee, Sweden) and Arijana Meštrović (FIP Programme Committee, Croatia)

Introduction

In some parts of the world, healthcare systems have improved dramatically over the years. Cancer and cardiac outcomes are better; waiting periods are shorter; patient satisfaction much higher, yet World Health Organization statistics still report uncontrolled health issues, such as neglected tropical diseases, immunisation needs and increasing mental illnesses. Almost 6 million children each year die under the age of five years, even though life expectancy worldwide is over 71 years.

Due to differences in financial background, legal frameworks and standards of practice quality, quality of care can be variable. Therefore, preventable illnesses are still widespread, and some health inequalities remain deep-rooted. Patients’ needs are changing, pharmaceutical science is opening new possibilities and new treatment options are emerging. Alongside the implementation of these new treatment options, we may face particular challenges in many areas of health. Our health systems need to adapt to take advantage of the opportunities that science and technology offer to patients, carers and those who serve them. Lifestyle issues also affect the outcomes of therapy, and the financial burden on our health systems.

Many countries will need to set out a clear direction for health reforms, showing why change is needed and what it will look like. Some initiatives will require new partnerships between regulation, practice and education, including patients, healthcare professionals, hospital and community pharmacy, and the pharmaceutical industry. New techniques will be needed to improve patient- and healthcare outcomes.

Pharmacists in different settings are the third largest healthcare professional group in the world after physicians and nurses. Hospital pharmacists are accepting new roles and developing clinical and pharmaco-economical skills; pharmacists in industry and science are embracing new technologies and expanding the use of IT assets. An emerging consensus among academics, professional organisations, and policymakers is that all pharmacists should be more visible and recognised in healthcare systems, especially those who work directly with the patients. They should adopt an expanded role in order to contribute to the safe, effective and efficient use of medicines — particularly when caring for people with multiple chronic conditions. Pharmacists already help to improve health by reducing drug-related adverse events and promoting better medication adherence, which in turn may help in reducing unnecessary provider visits, hospitalisations and readmissions, while strengthening integrated primary care delivery across the health system. New roles for pharmacists are currently emerging, such as the role of prescriber, vaccinator and health service provider.

As such, we all now have an opportunity to transform our practices in a way that will deliver better outcomes for patients. Through transformative thinking, modern educational methods, policy development and success in demonstrating the profession’s capacity, pharmacists can and should become part of the solution to the many challenges of the healthcare systems around the world. It is the responsibility of each of us to transform and advance the profession to improve the health of our patients and nations.

Programme

09:00 – 09:10 Introduction by the chairs

 

  1. 09:10 – 09:45 Transforming outcomes on the global level: Meeting the global health challenges
    Jim Campbell (Health Workforce Department/World Health Organization, UK)
  2. 09:45 – 10:20 Transforming outcomes on the organisational level: Needs-based healthcare system reforms
    Catherine Duggan (International Pharmaceutical Federation, the Netherlands)

10:20 – 10:40 Coffee/tea break

  1. 10:40 – 11:15 Transforming outcomes on the national/regional level: Transformational change and involving stakeholders
    Nicola Gray (NCD Child, UK)
  2. 11:15 – 11:50 Transforming outcomes on the patient level: Meeting the personal health challenges
    Sofia Crisostomo (Grupo de Ativistas em Tratamentos, Portugal)

11:50 – 12:00 Conclusion by the chairs

Learning Objectives

At the end of this session, participants will be able to:

  1. Describe how the combined healthcare workforce improves patient outcomes;
  2. Identify why healthcare reforms are necessary and pharmacy’s new and enhanced role in these reforms;
  3. Explain the concept of transformational change and how to involve different stakeholders for improved outcomes;
  4. Describe how pharmaceutical activities and strategies — in the new healthcare eco-system — can meet the global challenges of healthcare, and improve outcomes by being developed into the new health hub.

Type of session: Knowledge-based